Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Smith, R. E. Articles by Meador-Woodruff, J. H. Search for Related Content PubMed Citation Articles by Smith, R. E. Articles by Meador-Woodruff, J. H. Neurotransmitters Schizophrenia Spectrum Disorders

Expression of Excitatory Amino Acid Transporter Transcripts in the Thalamus of Subjects With Schizophrenia

OBJECTIVE: Recent investigations of schizophrenia have targeted glutamatergic neurotransmission, since phencyclidine, an N-methyl-D-aspartate (NMDA) receptor antagonist, can induce schizophreniform psychosis. The authors previously reported alterations in thalamic NMDA receptor subunit expression in schizophrenia, consistent with the hypothesis that thalamic glutamatergic hypofunction may contribute to the pathophysiology of this illness. In this study they generalized this hypothesis to include other molecules of the glutamate synapse, specifically excitatory amino acid transporters (EAATs), whose normal expression and regulation in the thalamus may also be disrupted in subjects with schizophrenia. METHOD: In situ hybridization with riboprobes specific for the human excitatory amino acid transporter transcripts EAAT1, EAAT2, and EAAT3 was performed in discrete thalamic nuclei in persons with schizophrenia and comparison subjects. RESULTS: Higher expressions of transcripts encoding EAAT1 and EAAT2, but not EAAT3, were detected in the thalamus of subjects with schizophrenia. CONCLUSIONS: These findings support the hypothesis of glutamatergic dysfunction in schizophrenia and suggest that molecules other than glutamate receptors are abnormally expressed in glutamatergic synapses in this illness.

This article has been cited by other articles:

				S. H. Fatemi and T. D. Folsom The Neurodevelopmental Hypothesis of Schizophrenia, Revisited Schizophr Bull, May 1, 2009; 35(3): 528 - 548. [Abstract] [Full Text] [PDF]

				T. Walsh, J. M. McClellan, S. E. McCarthy, A. M. Addington, S. B. Pierce, G. M. Cooper, A. S. Nord, M. Kusenda, D. Malhotra, A. Bhandari, et al. Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia Science, April 25, 2008; 320(5875): 539 - 543. [Abstract] [Full Text] [PDF]

				T. Flatscher-Bader, N. Zuvela, N. Landis, and P.A. Wilce Smoking and alcoholism target genes associated with plasticity and glutamate transmission in the human ventral tegmental area Hum. Mol. Genet., January 1, 2008; 17(1): 38 - 51. [Abstract] [Full Text] [PDF]

				R.-P. Behrendt Dysregulation of thalamic sensory 'transmission' in schizophrenia: neurochemical vulnerability to hallucinations J Psychopharmacol, May 1, 2006; 20(3): 356 - 372. [Abstract] [PDF]

				S. M. Clinton, H. M. Ibrahim, K. A. Frey, K. L. Davis, V. Haroutunian, and J. H. Meador-Woodruff Dopaminergic Abnormalities in Select Thalamic Nuclei in Schizophrenia: Involvement of the Intracellular Signal Integrating Proteins Calcyon and Spinophilin Am J Psychiatry, October 1, 2005; 162(10): 1859 - 1871. [Abstract] [Full Text] [PDF]

				S. M. Clinton, V. Haroutunian, K. L. Davis, and J. H. Meador-Woodruff Altered Transcript Expression of NMDA Receptor-Associated Postsynaptic Proteins in the Thalamus of Subjects With Schizophrenia Am J Psychiatry, June 1, 2003; 160(6): 1100 - 1109. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us